Fig. 2From: Combined prognostic value of the SUVmax derived from FDG-PET and the lymphocyte-monocyte ratio in patients with stage IIIB-IV non-small cell lung cancer receiving chemotherapyReceiver operating characteristic curves for SUVmax and hematological markersBack to article page